Health & Fitness
Health and Fitness
Health and Fitness
Wed, January 14, 2009
Tue, January 13, 2009 RTI Biologics Announces Conference Call on 2009 Outlook
ALACHUA, Fla.--([ BUSINESS WIRE ])--RTI Biologics, Inc. (RTI) (Nasdaq:RTIX), the Florida-based processor of orthopedic, dental, surgical specialties and other biologic implants, will be hosting a guidance conference call to discuss our 2009 outlook on Friday, Jan. 16, 2009 at 9:00 a.m.
The conference call can be accessed by dialing (877) 856-1960, passcode 5141974. The Web cast can be accessed through the investor section of RTI's Web site at [ www.rtix.com ]. A telephone replay of the call will be available through April 30, 2009 and can be accessed by calling (888) 203-1112, passcode 5141974; the replay will also be available at [ www.rtix.com ].
About RTI Biologics Inc.
RTI Biologics, Inc. is the leading provider of sterile biological implants for surgeries around the world with a commitment to advancing science, safety and innovation. RTI prepares human donated tissue and bovine tissue for transplantation through extensive testing and screening, precision shaping and proprietary, validated sterilization processes. These allograft and xenograft implants are used in orthopedic, dental, hernia and other specialty surgeries.
RTI's innovations continuously raise the bar of science and safety for biologics—from being the first company to offer precision-tooled bone implants and assembled technology to maximize each gift of donation, to inventing fully validated sterilization processes that include viral inactivation steps. Two such processes, the BioCleanse® Tissue Sterilization Process and the Tutoplast® process, sterilize tissue, are clinically successful and are scientifically proven to eliminate donor-to-recipient disease transmission risk while preserving tissue strength and biocompatibility. These processes have a proven record of more than two million implants distributed with zero incidence of infection. In addition, RTI pastes are sterilized through the demineralization process, a validated viral inactivation step.
The company is leading the evolution of biologics once again by offering a bovine based biological matrix, providing surgeons an expanded supply of safe, sterile tissue for their patients.
RTI's worldwide corporate headquarters are located in Alachua, Fla., with international facilities in Neunkirchen, Germany, and Aix-en-Provence, France. The company is accredited by the American Association of Tissue Banks.
